A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae
Metadatos
Mostrar el registro completo del ítemAutor
Solorzano Puerto, Antonio; Gutiérrez Fernández, José; Román, Eva; Luna Del Castillo, Juan De Dios; Roman, Juan; Liébana Ureña, José; Piédrola Angulo, GonzaloEditorial
Elsevier
Fecha
2007-08Referencia bibliográfica
Sorlozano A, Gutierrez J, Roman E, de Dios Luna J, Roman J, Liebana J, Piedrola G. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae. Diagn Microbiol Infect Dis. 2007 Aug;58(4):487-9.
Resumen
We evaluated the activity of several antibiotics against 225 clinical isolates of Staphylococcus aureus and 252 isolates of Streptococcus agalactiae. Only tigecycline, glycopeptides, and linezolid were active against all the isolates of S. aureus, whereas the beta-lactams were also active against S. agalactiae. Tigecycline could be a good alternative to ampicillin in the treatment of group B Streptococcus infections in patients allergic to beta-lactam.